Health challenges in the EU in the pandemic context - Related Opinions
Displaying 1 - 10 of 20
Trade Policy Review - An Open, Sustainable and Assertive Trade Policy
In this opinion the EESC:
- Welcomes Europe's Beating Cancer Plan as a milestone in the fight against cancer and calls for a concrete roadmap for its implementation, with performance indicators, realistic timeframes and close involvement of Social Partners (SP) and Civil Society Organisations (CSO).
- Considers important that the EU and Member States ensure the availability of igh-quality, accessible healthcare infrastructure and effective support systems for patients' physical and mental well-being.
- Asks for the negative consequences caused by the COVID-19 pandemic in accessing to health services to be urgently addressed, recognising as well the supportive role SP and CSO can play in this area.
The opinion, presenting EESC's position on the four proposals of the Health package published by the European Commission in November 2020, supports and welcomes these initiatives but draws the attention on some elements.
- The EU and Member States should ensure that everyone has equal access to quality, well staffed, well equipped health and social services. This is particularly important in the context of the COVID-19 pandemic which has deepened existing inequalities.
- Special attention in future EU policies should be given to healthcare workers and the need to improve working conditions, including pay, recruitment and retention, as well as their health and safety.
- The new EU health package should be combined with the roll-out of the European Pillar of Social Rights (EPSR), particularly its principles 12, 16, 17 and 18 and the Action Plan on the EPSR. It should also be part of achieving Sustainable Development Goal (SDG) 3.
The Commission proposes a new pharmaceutical strategy for Europe. It is a patient-centred strategy that aims to ensure the quality and safety of medicines, while boosting the sector’s global competitiveness. The EU needs to make sure that patients have access to high-quality, effective and safe medicines. It will foster patient access to innovative and affordable medicines. It will support the competitiveness and innovative capacity of the EU’s pharmaceutical industry.
In September 2020, the European Commission presented the Action Plan on Critical Raw Materials, which also contains the 2020 List of Critical Raw Materials.
This EESC opinion will respond to the European Commission's proposal for a regulation on establishing a European Climate Law and it will look into the role of citizens in driving the transformation towards climate neutrality.
Displaying 1 - 10 of 20